Aleksi Tarkkonen, Iiris Kyläheiko, Jussi Inkeri, Marika I Eriksson, Lena M Thorn, Paula A Summanen, Turgut Tatlisumak, Per-Henrik Groop, Jukka Putaala, Daniel Gordin, Juha Martola
{"title":"Progression of Cerebral Small Vessel Disease Among Neurologically Asymptomatic Middle-Aged Individuals With Type 1 Diabetes.","authors":"Aleksi Tarkkonen, Iiris Kyläheiko, Jussi Inkeri, Marika I Eriksson, Lena M Thorn, Paula A Summanen, Turgut Tatlisumak, Per-Henrik Groop, Jukka Putaala, Daniel Gordin, Juha Martola","doi":"10.2337/dc24-1825","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the potential progression rate of cerebral small vessel disease (CSVD) in brain MRI among neurologically asymptomatic middle-aged individuals with type 1 diabetes.</p><p><strong>Research design and methods: </strong>A total of 172 individuals with type 1 diabetes were re-examined with brain MRI 7.5 years after their initial visit. Baseline predictors of changes in CSVD, particularly cerebral microbleeds (CMBs) and white matter hyperintensities (WMHs) were analyzed.</p><p><strong>Results: </strong>The proportion of individuals with type 1 diabetes with CSVD increased from 36% to 70% (P < 0.001), CMBs increased from 17% to 33% (P < 0.001), and WMHs from 23% to 63% (P < 0.001) at follow-up. The increase in CMBs was associated with baseline systolic blood pressure, HbA1c, and preexisting CMBs. The increases in CSVD and WMHs were associated only with age.</p><p><strong>Conclusions: </strong>The prevalence of CSVD doubled over a 7.5-year period in middle-aged individuals with type 1 diabetes.</p>","PeriodicalId":93979,"journal":{"name":"Diabetes care","volume":" ","pages":"776-780"},"PeriodicalIF":16.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/dc24-1825","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the potential progression rate of cerebral small vessel disease (CSVD) in brain MRI among neurologically asymptomatic middle-aged individuals with type 1 diabetes.
Research design and methods: A total of 172 individuals with type 1 diabetes were re-examined with brain MRI 7.5 years after their initial visit. Baseline predictors of changes in CSVD, particularly cerebral microbleeds (CMBs) and white matter hyperintensities (WMHs) were analyzed.
Results: The proportion of individuals with type 1 diabetes with CSVD increased from 36% to 70% (P < 0.001), CMBs increased from 17% to 33% (P < 0.001), and WMHs from 23% to 63% (P < 0.001) at follow-up. The increase in CMBs was associated with baseline systolic blood pressure, HbA1c, and preexisting CMBs. The increases in CSVD and WMHs were associated only with age.
Conclusions: The prevalence of CSVD doubled over a 7.5-year period in middle-aged individuals with type 1 diabetes.